Literature DB >> 30662078

Performance of urinary survivin as a non-invasive molecular marker of bladdercarcinoma in a schistosomiasis endemic area.

Abubakar S Muhammad1, Ismaila A Mungadi1, Enemeka D Ndodu2, Garba D Kalayi3.   

Abstract

OBJECTIVE: To compare the sensitivity, specificity, positive predictive value, negative predictive value of urinary survivin and that of urine cytology in the diagnosis of bladder carcinoma in a schistosoma endemic area. DESIGN AND
SETTING: This is a 12-month prospective study of patients with features of bladder carcinoma as study group and patients with other urologic conditions and healthy volunteers as control group. PARTICIPANTS: Patients with features of bladder carcinoma formed the study group, while patients with other urological conditions and healthy volunteers formed the control group.
RESULTS: There were 52 patients in study group and 36 patients in control group. The mean ages of patients in the study and control groups were 47.17 ± 17.00 and 44.19 ± 18.89 years respectively. There were 48 males and 4 females in the study group, giving a male: female ratio of 12:1. Thirty-one (60 %) of the patients were farmers and 44 patients (85%) had history suggestive of schistosomiasis at childhood. The sensitivity of urine cytology and survivin in the study were 29.1% and 100.0% respectively. The specificity of urine cytology and survivin were 100.0% and 100.0% respectively (p= 0.05). The marker was associated with false positive (FP) results in patients with prostate cancer.
CONCLUSION: Urinary survivin is highly sensitive, specific and predictive of bladder carcinoma in our environment. The marker is associated with false positive results in patients with prostate cancer. FUNDING: By authors.

Entities:  

Keywords:  schistosomiasis; sensitivity; specificity; survivin; urinary bladder carcinoma

Mesh:

Substances:

Year:  2018        PMID: 30662078      PMCID: PMC6326538          DOI: 10.4314/gmj.v52i2.2

Source DB:  PubMed          Journal:  Ghana Med J        ISSN: 0016-9560


  11 in total

1.  World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects.

Authors: 
Journal:  Bull World Health Organ       Date:  2003-07-02       Impact factor: 9.408

Review 2.  Urine markers for detection and surveillance of non-muscle-invasive bladder cancer.

Authors:  Derya Tilki; Maximilian Burger; Guido Dalbagni; H Barton Grossman; Oliver W Hakenberg; Juan Palou; Oliver Reich; Morgan Rouprêt; Shahrokh F Shariat; Alexandre R Zlotta
Journal:  Eur Urol       Date:  2011-06-12       Impact factor: 20.096

3.  Evaluation of survivin reverse transcriptase-polymerase chain reaction for noninvasive detection of bladder cancer.

Authors:  Omar Moussa; Hassan Abol-Enein; Nabil K Bissada; Thomas Keane; Mohamed A Ghoneim; Dennis K Watson
Journal:  J Urol       Date:  2006-06       Impact factor: 7.450

4.  Urine detection of survivin and diagnosis of bladder cancer.

Authors:  S D Smith; M A Wheeler; J Plescia; J W Colberg; R M Weiss; D C Altieri
Journal:  JAMA       Date:  2001-01-17       Impact factor: 56.272

5.  Diagnostic role of survivin in urinary bladder cancer.

Authors:  Anupam Kumar Srivastava; Pankaj Kumar Singh; Kirti Srivastava; Dhramveer Singh; Divakar Dalela; Srikanta Kumar Rath; Madhu Mati Goel; Madan Lal Brahma Bhatt
Journal:  Asian Pac J Cancer Prev       Date:  2013

Review 6.  The global burden of urinary bladder cancer.

Authors:  D Maxwell Parkin
Journal:  Scand J Urol Nephrol Suppl       Date:  2008-09

7.  The expression and significance of survivin mRNA in urinary bladder carcinomas.

Authors:  Haidong Wang; Xiaoqing Xi; Xianguo Kong; Guohua Huang; Gen Ge
Journal:  J Cancer Res Clin Oncol       Date:  2004-05-08       Impact factor: 4.553

Review 8.  Survivin: a promising biomarker for detection and prognosis of bladder cancer.

Authors:  Vitaly Margulis; Yair Lotan; Shahrokh F Shariat
Journal:  World J Urol       Date:  2007-10-26       Impact factor: 4.226

9.  Urinary bladder cancer and schistosomiasis in North-Western Nigeria.

Authors:  I A Mungadi; S A Malami
Journal:  West Afr J Med       Date:  2007 Jul-Sep

10.  Regulation of mitochondrial Smac/DIABLO-selective release by survivin.

Authors:  G Ceballos-Cancino; M Espinosa; V Maldonado; J Melendez-Zajgla
Journal:  Oncogene       Date:  2007-06-04       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.